TERMINAL COMPONENT OF COMPLEMENT (C9) IN CEREBROSPINAL FLUID OF PATIENTS WITH MULTIPLE SCLEROSIS
- 1 August 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 324 (8397) , 251-255
- https://doi.org/10.1016/s0140-6736(84)90298-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Immunoaffinity purification of human complement component C9 using monoclonal antibodiesJournal of Immunological Methods, 1983
- Immunoradiometric assay for human complement component C9 utilising monoclonal antibodiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Antibrain antibodies in multiple sclerosisJournal of the Neurological Sciences, 1982
- Antibody-independent complement activation by myelin via the classical complement pathway.The Journal of Experimental Medicine, 1982
- Intracellular free calcium as a pathogen in cell damage initiated by the immune systemCellular and Molecular Life Sciences, 1981
- The enigma of oligoclonal immunoglobulin G in cerebrospinal fluid from multiple sclerosis patientsImmunology Today, 1981
- Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosisClinical Immunology and Immunopathology, 1980
- Complement‐dependent serumNeurology, 1978
- Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophoreNature, 1977
- REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLSThe Journal of Experimental Medicine, 1970